Synthesis of Fe 3 O 4 -Gold hybrid nanoparticles coated by bovine serum albumin as a contrast agent in MR imaging
Heliyon, ISSN: 2405-8440, Vol: 9, Issue: 3, Page: e13874
2023
- 19Citations
- 38Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations19
- Citation Indexes19
- 19
- CrossRef17
- Captures38
- Readers38
- 38
- Mentions1
- News Mentions1
- News1
Most Recent News
Study Findings from Zanjan University of Medical Sciences Provide New Insights into Nanoparticles (Synthesis of Fe3O4-Gold hybrid nanoparticles coated by bovine serum albumin as a contrast agent in MR imaging)
2023 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Life Science Daily -- Researchers detail new data in nanoparticles. According to
Article Description
Despite the over spatial separation and the ability to determine soft tissues, insufficient contrast is the shortcoming of magnetic resonance imaging (MRI) that could be circumvented by the use of contrast agents. The use of MRI contrast agents are widely applied to enhance the vision of internal body structures. Nano-sized contrast materials have unique application advantages compared to other contrast agents due to their size and shape. However, for contrast agents such as bare iron (II, III) oxide (Fe 3 O 4 ) magnetic nanoparticles (NPs), aggregation and accumulation are the main shortcomings. Thus, surface modifications are necessary for their use in biopharmaceutical applications. Gold, Au, nanoparticles are of big interesting for use in biomedical purposes due to their chemical stability and oxidation resistance. In this study, we synthesized magnetic Fe 3 O 4 –Au hybrid NPs with a facile method and coated them with bovine serum albumin (BSA) to increase their chemical stability and biocompatibility. Afterwards, the hybrid nanosystem was characterized by some methods, and their potential to increase MRI contrast was investigated by the phantom MRI experiments. Our data showed that the signal intensity on MR images was significantly reduced, thus confirming the contrast ability of the formulated Fe 3 O 4 –Au-BSA NPs.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2405844023010812; http://dx.doi.org/10.1016/j.heliyon.2023.e13874; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85148666105&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36895357; https://linkinghub.elsevier.com/retrieve/pii/S2405844023010812; https://dx.doi.org/10.1016/j.heliyon.2023.e13874
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know